Literature DB >> 15144951

Radiation activates HIF-1 to regulate vascular radiosensitivity in tumors: role of reoxygenation, free radicals, and stress granules.

Benjamin J Moeller1, Yiting Cao, Chuan Y Li, Mark W Dewhirst.   

Abstract

Through a poorly understood mechanism, tumors respond to radiation by secreting cytokines capable of inhibiting apoptosis in endothelial cells, thereby diminishing treatment response by minimizing vascular damage. We reveal here that this pathway is governed by a major angiogenesis regulator, HIF-1. Following radiotherapy, tumor reoxygenation leads to: (1) nuclear accumulation of HIF-1 in response to reactive oxygen, and (2) enhanced translation of HIF-1-regulated transcripts secondary to stress granule depolymerization. The resulting increase in HIF-1-regulated cytokines enhances endothelial cell radioresistance. Inhibiting postradiation HIF-1 activation significantly increases tumor radiosensitivity as a result of enhanced vascular destruction. These data describe novel pathways contributing significantly to our understanding of HIF-1 regulation which may be major determinants of tumor radiosensitivity, potentially having high clinical relevance.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15144951     DOI: 10.1016/s1535-6108(04)00115-1

Source DB:  PubMed          Journal:  Cancer Cell        ISSN: 1535-6108            Impact factor:   31.743


  377 in total

1.  Impact of stromal sensitivity on radiation response of tumors implanted in SCID hosts revisited.

Authors:  Mónica García-Barros; Tin Htwe Thin; Jerzy Maj; Carlos Cordon-Cardo; Adriana Haimovitz-Friedman; Zvi Fuks; Richard Kolesnick
Journal:  Cancer Res       Date:  2010-10-05       Impact factor: 12.701

Review 2.  Posttranscriptional regulation of cancer traits by HuR.

Authors:  Kotb Abdelmohsen; Myriam Gorospe
Journal:  Wiley Interdiscip Rev RNA       Date:  2010-05-06       Impact factor: 9.957

3.  Tumor radiation response enhancement by acoustical stimulation of the vasculature.

Authors:  Gregory J Czarnota; Raffi Karshafian; Peter N Burns; Shun Wong; Azza Al Mahrouki; Justin W Lee; Amanda Caissie; William Tran; Christina Kim; Melissa Furukawa; Emily Wong; Anoja Giles
Journal:  Proc Natl Acad Sci U S A       Date:  2012-07-09       Impact factor: 11.205

Review 4.  Imaging tumor hypoxia to advance radiation oncology.

Authors:  Chen-Ting Lee; Mary-Keara Boss; Mark W Dewhirst
Journal:  Antioxid Redox Signal       Date:  2014-03-24       Impact factor: 8.401

5.  Targeting heat shock protein 90 overrides the resistance of lung cancer cells by blocking radiation-induced stabilization of hypoxia-inducible factor-1alpha.

Authors:  Woo-Young Kim; Seung Hyun Oh; Jong-Kyu Woo; Waun Ki Hong; Ho-Young Lee
Journal:  Cancer Res       Date:  2009-01-27       Impact factor: 12.701

6.  Cancer Stem Cells under Hypoxia as a Chemoresistance Factor in Breast and Brain.

Authors:  Spencer W Crowder; Daniel A Balikov; Yu-Shik Hwang; Hak-Joon Sung
Journal:  Curr Pathobiol Rep       Date:  2014-03

7.  Radiation-induced galectin-1 by endothelial cells: a promising molecular target for preferential drug delivery to the tumor vasculature.

Authors:  Meenakshi Upreti; Azemat Jamshidi-Parsian; Scott Apana; Marc Berridge; Daniel A Fologea; Nathan A Koonce; Ralph L Henry; Robert J Griffin
Journal:  J Mol Med (Berl)       Date:  2012-10-23       Impact factor: 4.599

Review 8.  Linking the history of radiation biology to the hallmarks of cancer.

Authors:  Mary-Keara Boss; Robert Bristow; Mark W Dewhirst
Journal:  Radiat Res       Date:  2014-05-08       Impact factor: 2.841

9.  Challenges and opportunities of using stereotactic body radiotherapy with anti-angiogenesis agents in tumor therapy.

Authors:  Xiaowen Sun; Lei Deng; You Lu
Journal:  Chin J Cancer Res       Date:  2018-02       Impact factor: 5.087

10.  High-dose radiation with bone marrow transfer prevents neurodegeneration in an inherited glaucoma.

Authors:  Michael G Anderson; Richard T Libby; Douglas B Gould; Richard S Smith; Simon W M John
Journal:  Proc Natl Acad Sci U S A       Date:  2005-03-09       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.